According to Natco Pharma
's latest financial reports the company has $0.14 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $0.13 B | 36.71% |
2022-03-31 | $0.10 B | -9.99% |
2021-03-31 | $0.11 B | -6.98% |
2020-03-31 | $0.11 B | -21.42% |
2019-03-31 | $0.15 B | 17.46% |
2018-03-31 | $0.12 B | 512.4% |
2017-03-31 | $21.17 M | 30.98% |
2016-03-31 | $16.16 M | 621.86% |
2015-03-31 | $2.23 M | 27.23% |
2014-03-31 | $1.76 M | -11.24% |
2013-03-31 | $1.98 M | -72.56% |
2012-03-31 | $7.22 M | -2.85% |
2011-03-31 | $7.43 M | -42.09% |
2010-03-31 | $12.84 M | -4.23% |
2009-03-31 | $13.41 M | -36.42% |
2008-03-31 | $21.09 M | 4.63% |
2007-03-31 | $20.16 M | 21.99% |
2006-03-31 | $16.53 M | -20.19% |
2005-03-31 | $20.71 M |